Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3014591	s-leppäe	u/ml (—)	127	127	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Vasomotor and allergic rhinitis

8.76

26.18

1.0

—

Allergic rhinitis

7.37

22.12

1.0

—

Pollen allergy

7.57

18.36

1.0

—

Disorders of conjunctiva

4.12

14.37

1.0

—

Conjunctivitis

4.07

13.68

1.0

—

Examination and observation for other reasons

5.59

12.02

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3.83

9.56

1.0

—

Asthma (mode)

4.05

8.39

1.0

—

Allergic conjunctivitis

3.41

8.38

1.0

—

Asthma, excluding more controls

4.14

8.21

1.0

—

Unspecified fall

4.02

8.05

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

6.56

7.86

1.0

—

Asthma

3.83

7.51

1.0

—

Asthma (only as main-diagnosis), excluding more controls

4.04

7.38

1.0

—

Asthma (only as main-diagnosis)

3.75

6.80

1.0

—

Asthma, including avohilmo

2.64

6.40

1.0

—

Dermatitis and eczema

2.59

5.92

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.99

5.81

1.0

—

Asthma (diagnoses ohter than nonallergic)

2.70

5.76

1.0

—

Exposure to other specified factors

2.76

5.73

1.0

—

Medical observation and evaluation for suspected diseases and conditions

3.70

5.61

1.0

—

Neurotic, stress-related and somatoform disorders

2.64

5.49

1.0

—

Anxiety disorders

2.60

5.33

1.0

—

Asthma, unspecified (mode), excluding more controls

3.86

5.18

1.0

—

3.20

5.08

1.0

—

Other diseases of upper respiratory tract

2.70

5.06

1.0

—

Chronic sinusitis

4.32

4.91

1.0

—

Anxiety disorders, excluding more controls

2.55

4.74

1.0

—

Transport accidents

3.32

4.68

1.0

—

Asthma, unspecified (mode)

3.54

4.64

1.0

—

Asthma, hospital admission 2, infections

2.92

4.63

1.0

—

Asthma-related infections

2.92

4.63

1.0

—

Acute sinusitis

2.94

4.61

1.0

—

Dental pulpitis, including avohilmo

2.42

4.59

1.0

—

Recurrent or chronic depression

3.32

4.42

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.32

4.41

1.0

—

All anxiety disorders

2.60

4.12

1.0

—

Other and unspecified effects of external causes

3.19

4.05

1.0

—

Unspecified acute lower respiratory infection

5.56

3.97

1.0

—

Atopic dermatitis

2.51

3.91

1.0

—

Disease of hard tissues of teeth, NOS

3.57

3.90

1.0

—

Malaise and fatigue

2.97

3.90

1.0

—

Dermatitis

2.87

3.86

1.0

—

Conjunctivitis (acute, non atopic)

3.93

3.77

1.0

—

Vocal cord dysfunction

7.18

3.75

1.0

—

Injuries to the neck

4.14

3.69

1.0

—

Anxiety (asthma-related co-morbidities)

2.44

3.65

1.0

—

Diseases of the respiratory system

3.01

3.64

1.0

—

Injuries to the ankle and foot

2.32

3.54

1.0

—

Abnormalities of breathing

2.22

3.51

1.0

—

Disturbances of skin sensation

3.61

3.49

1.0

—

Other pulmonary diagnosis

2.71

3.43

1.0

—

Excluding asthma or asthma-COPD overlap

2.71

3.43

1.0

—

COPD differential diagnosis

2.71

3.43

1.0

—

ILD differential diagnosis

2.71

3.43

1.0

—

Disorders of eyelid, lacrimal system and orbit

2.36

3.41

1.0

—

Adverse effects, not elsewhere classified

3.64

3.28

1.0

—

Migraine without aura

3.53

3.19

1.0

—

Non-allergic asthma (mode), excluding more controls

5.28

3.16

1.0

—

Depression

2.11

3.15

1.0

—

Urticaria and erythema

2.80

3.08

1.0

—

Asthma, hospital admissions , main diagnosis only

2.16

3.04

1.0

—

Temporomandibular joint disorders, including avohilmo

2.43

3.02

1.0

—

Other viral diseases

2.56

2.99

1.0

—

Diseases of middle ear and mastoid

2.34

2.98

1.0

—

Other and unspecified urticaria

3.85

2.97

1.0

—

Allergic asthma (mode), excluding more controls

4.20

2.93

1.0

—

Dentofacial anomalies [including malocclusion]

2.17

2.91

1.0

—

Persons encountering health services for examination and investigation

2.77

2.88

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

4.10

2.88

1.0

—

Speech therapy

3.71

2.87

1.0

—

Diseases of the skin and subcutaneous tissue

2.12

2.87

1.0

—

Sleep apnoea, including avohilmo

2.15

2.81

1.0

—

Other headache syndromes

2.76

2.80

1.0

—

Other and unspecified dermatitis

2.64

2.79

1.0

—

Non-allergic asthma (mode)

4.40

2.76

1.0

—

Chronic lower respiratory diseases

1.91

2.74

1.0

—

Other diseases of hard tissues of teeth

2.90

2.74

1.0

—

Episodal and paroxysmal disorders

1.95

2.69

1.0

—

Voice disturbances

3.45

2.68

1.0

—

Somatoform disorder

4.21

2.67

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.49

2.67

1.0

—

Migraine without aura and triptan purchases

3.75

2.67

1.0

—

Selective serotonin reuptake inhibitors

2.06

2.63

1.0

—

Urticaria

2.93

2.61

1.0

—

Allergic asthma (mode)

3.67

2.61

1.0

—

Superficial injury of wrist and hand

3.34

2.60

1.0

—

Other anxiety disorders

2.34

2.60

1.0

—

Other acute lower respiratory infections

2.38

2.59

1.0

—

Female infertility

2.82

2.57

1.0

—

Nonorganic sleeping disorders, excluding more controls

4.00

2.56

1.0

—

Other antidepressants

2.07

2.55

1.0

—

Sciatica+with lumbago

2.53

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

2.89

2.52

1.0

—

Headache

2.16

2.52

1.0

—

Diseases of the musculoskeletal system and connective tissue

2.32

2.51

1.0

—

Any gastric operation

1.99

2.50

1.0

—

GASTRO-related operations

1.99

2.50

1.0

—

Acute upper respiratory infections

1.98

2.49

1.0

—

Injuries to the hip and thigh

2.72

2.47

1.0

—

Caries of enamel

1.96

2.43

1.0

—

Asthma/COPD (KELA code 203)

1.94

2.42

1.0

—

Fibromyalgia

5.01

2.40

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

5.00

2.40

1.0

—

Sleep apnoea

2.06

2.39

1.0

—

Other soft tissue disorders, not elsewhere classified

1.98

2.38

1.0

—

Dermatographic urticaria

6.26

2.37

1.0

—

Pain in joint

2.45

2.36

1.0

—

Endometriosis

2.82

2.35

1.0

—

Phobic anxiety disorders

4.12

2.35

1.0

—

Gastrointestinal diseases

2.15

2.35

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2.82

2.34

1.0

—

Hypothyroidism, strict autoimmune

2.12

2.33

1.0

—

Mood disorders, excluding more controls

1.99

2.33

1.0

—

Asthma and allergy

4.07

2.33

1.0

—

Bronchitis

1.89

2.31

1.0

—

Covid-19 suspected case

2.94

2.27

1.0

—

KRA_PSY_EATING, excluding more controls

4.60

2.26

1.0

—

Triptan medication for migraine, min. 3 purchases

2.06

2.26

1.0

—

Dental caries, including avohilmo

2.25

2.24

1.0

—

Asthma and allergy, excluding more controls

3.84

2.22

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.10

2.22

1.0

—

Other menopausal disorders

3.38

2.22

1.0

—

Abdominal and pelvic pain

1.98

2.21

1.0

—

Symptoms and signs involving speech and voice

2.86

2.20

1.0

—

Irritable bowel syndrome

2.68

2.20

1.0

—

Diseases of the eye and adnexa

2.04

2.19

1.0

—

Mood [affective] disorders

1.87

2.19

1.0

—

Mood disorders

1.87

2.18

1.0

—

Depression or dysthymia

2.23

2.15

1.0

—

Obesity related asthma

3.00

2.14

1.0

—

Postmenopausal bleeding

4.15

2.13

1.0

—

Nerve, nerve root and plexus disorders

1.91

2.12

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.95

2.12

1.0

—

Generalized anxiety disorder

3.20

2.09

1.0

—

Other viral diseases

2.44

2.08

1.0

—

Long labour

2.76

2.08

1.0

—

Diseases of the ear and mastoid process

1.80

2.06

1.0

—

Other disorders of lacrimal gland

2.63

2.00

1.0

—

Exposure to unspecified factor

1.82

1.99

1.0

—

Other viral diseases, not elsewhere classified

2.49

1.98

1.0

—

Caries of dentine, including avohilmo

2.07

1.98

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.95

1.97

1.0

—

Sleep disorders (combined)

1.79

1.94

1.0

—

Disorders of lacrimal system

2.44

1.91

1.0

—

Acute suppurative otitis media

2.33

1.89

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.77

1.87

1.0

—

Endometriosis of pelvic peritoneum

3.18

1.86

1.0

—

Other keratitis

3.53

1.83

1.0

—

Dyspnoea

1.89

1.83

1.0

—

Injury of muscle and tendon at hip and thigh level

4.17

1.82

1.0

—

Other complications of surgical and medical care, not elsewhere classified

4.17

1.82

1.0

—

Adenomyosis (Endometriosis of uterus)

4.17

1.82

1.0

—

Diseases of pulp and periapical tissues and dental caries

2.20

1.81

1.0

—

Inguinal hernia

2.36

1.80

1.0

—

Other nutritional deficiencies

1.93

1.80

1.0

—

Otitis externa

2.76

1.79

1.0

—

Soft tissue disorders

1.76

1.77

1.0

—

Obesity and other hyperalimentation

1.95

1.77

1.0

—

Depression medications

2.41

1.75

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.09

1.74

1.0

—

Diseases of oesophagus, stomach and duodenum

1.77

1.73

1.0

—

Nonorganic sleeping disorders

2.67

1.72

1.0

—

Intestinal infectious diseases

1.76

1.71

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.80

1.71

1.0

—

Acute bronchitis

2.29

1.70

1.0

—

Codes for special purposes

2.06

1.69

1.0

—

Keratitis

2.50

1.66

1.0

—

Parasetamol

1.88

1.65

1.0

—

Chronic diseases of tonsils and adenoids

1.95

1.65

1.0

—

Endometriosis ASRM stages 1,2

2.80

1.65

1.0

—

Oral corticosteroids

1.74

1.63

1.0

—

Any mental disorder

1.71

1.63

1.0

—

Desensitization to allergens

3.58

1.61

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.69

1.58

1.0

—

Other bacterial intestinal infections

2.69

1.58

1.0

—

Soft tissue disorders related to use, overuse and pressure

2.69

1.58

1.0

—

Non-selective monoamine reuptake inhibitors

2.49

1.58

1.0

—

Eating disorders

3.00

1.58

1.0

—

Eating disorder

3.00

1.58

1.0

—

Internal derangement of knee

2.31

1.57

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.78

1.56

1.0

—

Rotator cuff syndrome

2.25

1.55

1.0

—

1.70

1.55

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.25

1.53

1.0

—

Cough

2.25

1.53

1.0

—

FESS (DNB20)

3.34

1.52

1.0

—

Ethmoidectomy

3.34

1.52

1.0

—

Injuries to the wrist and hand

1.68

1.52

1.0

—

Other enthesopathies

2.59

1.51

1.0

—

Hypothyroidism, other/unspecified

1.75

1.51

1.0

—

Panic disorder

2.86

1.50

1.0

—

Acetic acid derivatives and related substances

2.80

1.50

1.0

—

Genitourinary diseases

1.96

1.49

1.0

—

Low back pain

1.82

1.49

1.0

—

Migraine

1.88

1.49

1.0

—

Obesity

1.86

1.49

1.0

—

Codeine

1.71

1.48

1.0

—

Extrapyramidal and movement disorders

2.43

1.47

1.0

—

Fenamates

3.39

1.46

1.0

—

Infections of the skin and subcutaneous tissue

1.88

1.45

1.0

—

Diseases of oral cavity, salivary glands and jaws

2.26

1.44

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.38

1.44

1.0

—

Restless leg syndrome

3.13

1.44

1.0

—

Otitis externa, unspecified

3.13

1.44

1.0

—

Other or unspecified ileus, impaction or obstruction

3.12

1.43

1.0

—

Ganglion

2.73

1.43

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.97

1.43

1.0

—

Pain in limb

1.77

1.42

1.0

—

Other disorders of eyelid

2.47

1.42

1.0

—

Pain (limb, back, neck, head abdominally)

1.91

1.41

1.0

—

Certain infectious and parasitic diseases

1.67

1.40

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.65

1.40

1.0

—

Gastro-oesophageal reflux disease

1.92

1.40

1.0

—

Lower back pain or/and sciatica

1.65

1.37

1.0

—

Continuous positive airway pressure

2.66

1.37

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.21

1.36

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

2.61

1.36

1.0

—

Enthesopathies of lower limb, excluding foot

2.61

1.36

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.66

1.36

1.0

—

Convulsions, not elsewhere classified

0.00

1.34

0.0

1.0

—

Disorders of vitreous body and globe

2.16

1.34

1.0

—

Other medical care

2.13

1.32

1.0

—

Factors influencing health status and contact with health services

2.74

1.30

1.0

—

Childhood allergy (age < 16)

2.12

1.30

1.0

—

Other extrapyramidal and movement disorders in other diseases

2.50

1.30

1.0

—

Asthma-related pneumonia

2.35

1.29

1.0

—

Asthma-related pneumonia or sepsis

2.35

1.29

1.0

—

Asthma, hospital admissions 3, pneumonia

2.35

1.29

1.0

—

External causes of morbidity and mortality

1.88

1.28

1.0

—

Spinal stenosis

2.34

1.28

1.0

—

Obesity, other/unspecified

2.08

1.27

1.0

—

Intestinal infectious diseases

1.59

1.27

1.0

—

Disorders of synovium and tendon

1.95

1.26

1.0

—

Other maternal disorders predominantly related to pregnancy

1.79

1.25

1.0

—

Endometriosis of ovary

2.71

1.25

1.0

—

Use of hypnotics and sedatives

1.61

1.24

1.0

—

Car occupant injured in other and unspecified transport accidents

2.40

1.24

1.0

—

Diseases of salivary glands

2.22

1.24

1.0

—

Falls/tendency to fall

1.57

1.23

1.0

—

Acute pharyngitis

2.38

1.23

1.0

—

Hernia

1.68

1.22

1.0

—

Obesity due to excess calories

1.91

1.22

1.0

—

Infections, IBD-co-morbidities

2.75

1.22

1.0

—

Superficial injury of abdomen, lower back and pelvis

2.63

1.21

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.63

1.21

1.0

—

Persistent mood disorders

2.63

1.21

1.0

—

Other gastritis (incl. Duodenitis)

2.63

1.21

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.69

1.20

1.0

—

Myalgia

2.31

1.18

1.0

—

Systemic connective tissue disorders

2.11

1.18

1.0

—

Other specific joint derangements/joint disorders

1.66

1.18

1.0

—

Care involving use of rehabilitation procedures

1.79

1.18

1.0

—

Malignant neoplasm of breast, HER-positive

0.00

1.17

0.0

1.0

—

Disorders of vitreous body

2.09

1.17

1.0

—

Persons encountering health services for specific procedures and health care

1.54

1.17

1.0

—

Nonsuppurative otitis media

2.01

1.15

1.0

—

Superficial injury of ankle and foot

2.50

1.15

1.0

—

Inflammatory disease of uterus

2.50

1.15

1.0

—

Other female pelvic inflammatory diseases

2.50

1.15

1.0

—

Fracture of lumbar spine and pelvis

2.50

1.15

1.0

—

Cardiodefibrillation

2.49

1.15

1.0

—

Suicide or other Intentional self-harm

0.00

1.14

0.0

1.0

—

Fever of other and unknown origin

1.81

1.13

1.0

—

Special screening examination for infectious and parasitic diseases

2.34

1.12

1.0

—

Diseases of external ear

2.00

1.12

1.0

—

Accidents

1.70

1.10

1.0

—

Other disorders of patella

2.38

1.09

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

2.38

1.09

1.0

—

Blepharochalasis

2.38

1.09

1.0

—

Hypertrophy of breast in women and men

2.38

1.09

1.0

—

Chronic gastritis

2.38

1.09

1.0

—

Dental operations

2.05

1.08

1.0

—

Other joint disorders

1.57

1.08

1.0

—

Other diseases of intestines

1.51

1.07

1.0

—

Other and unspecified disorders of vitreous body

2.16

1.07

1.0

—

Viral and other specified intestinal infections

1.93

1.06

1.0

—

Cutaneous abscess, furuncle and carbuncle

2.12

1.05

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.12

1.05

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.12

1.05

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.85

1.05

1.0

—

Fall on same level

1.49

1.05

1.0

—

Other viral diseases, not elsewhere classified

2.12

1.05

1.0

—

Cardiac arrhythmias

1.68

1.05

1.0

—

Codeine or tramadol medication

1.53

1.04

1.0

—

Injury, poisoning and certain other consequences of external causes

1.88

1.04

1.0

—

Crohn disease

2.27

1.03

1.0

—

Neurological diseases, wide definition

1.96

1.03

1.0

—

Gestational diabetes (for exclusion)

1.81

1.02

1.0

—

Dizziness and giddiness

1.67

1.02

1.0

—

Impacted teeth

1.91

1.01

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.56

1.01

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

1.00

0.0

1.0

—

Other disorders of skin and subcutaneous tissue

1.78

1.00

1.0

—

Carpal tunnel syndrome

1.83

1.00

1.0

—

Other arrhythmias

1.70

1.00

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.51

1.00

1.0

—

Dorsalgia

1.53

0.99

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.85

0.99

1.0

—

Striking against or struck by other objects

1.84

0.98

1.0

—

Cervicalgia

2.17

0.98

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.75

0.97

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.97

0.0

1.0

—

Sequelae of external causes of morbidity and mortality

0.00

0.97

0.0

1.0

—

Opioids

1.52

0.97

1.0

—

Focal epilepsy, strict definition

0.00

0.96

0.0

1.0

—

Focal epilepsy

0.00

0.96

0.0

1.0

—

Triptan medication for migraine, single purchase ok

1.55

0.95

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.55

0.95

1.0

—

Inflammatory diseases of female pelvic organs

1.61

0.94

1.0

—

Deforming dorsopathies

1.89

0.94

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

2.22

0.93

1.0

—

Intestinal stricture

2.22

0.93

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.58

0.92

1.0

—

Abnormalities of heart beat

1.85

0.91

1.0

—

Benzodiazepine use

1.51

0.91

1.0

—

Fissure and fistula of anal and rectal regions

2.14

0.91

1.0

—

Colonic or urogenital fistula

2.14

0.91

1.0

—

Supervision of normal pregnancy

1.99

0.91

1.0

—

Mouth breathing

1.90

0.88

1.0

—

Injuries to the shoulder and upper arm

1.57

0.88

1.0

—

Gonarthrosis

1.79

0.88

1.0

—

Antenatal screening

1.87

0.87

1.0

—

Medical abortion

0.52

0.87

1.0

—

Sleep disorders

1.51

0.87

1.0

—

Other external causes of accidental injury

1.60

0.87

1.0

—

Other/unspecified dorsalgia

1.84

0.86

1.0

—

Varicose veins

1.83

0.86

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.47

0.85

1.0

—

Maternal care for other conditions predominantly related to pregnancy

1.96

0.85

1.0

—

Diaphragmatic hernia

1.94

0.84

1.0

—

Finngen Rheumatological endpoints

1.47

0.84

1.0

—

Suppurative and unspecified otitis media

1.71

0.83

1.0

—

Spondylosis

1.76

0.83

1.0

—

Venous thromboembolism

1.76

0.83

1.0

—

Delivery

1.71

0.83

1.0

—

ILD medications

1.43

0.82

1.0

—

Complications of procedures, not elsewhere classified

1.54

0.82

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.51

0.82

1.0

—

1.51

0.82

1.0

—

Other arthritis (FG)

1.88

0.81

1.0

—

Embedded and impacted teeth

1.76

0.81

1.0

—

General symptoms and signs

1.44

0.81

1.0

—

Bleeding

0.51

0.80

1.0

—

Haemorrhage from respiratory passages

0.00

0.79

0.0

1.0

—

COPD/asthma/ILD related infections

1.46

0.79

1.0

—

COPD/asthma related infections

1.46

0.79

1.0

—

Pedal cyclist injured in transport accident

1.82

0.79

1.0

—

Poor fetal growth

0.00

0.79

0.0

1.0

—

Peripheral artery disease

0.00

0.78

0.0

1.0

—

Diagnoses used for exclusion with ILD

0.00

0.78

0.0

1.0

—

Shoulder lesions

1.71

0.78

1.0

—

Persons encountering health services in other circumstances, wide

1.43

0.78

1.0

—

Autoimmune diseases

1.43

0.78

1.0

—

Other retinal disorders

1.73

0.77

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.77

0.0

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.76

0.0

1.0

—

Meniscus derangement

1.68

0.75

1.0

—

Neurological diseases

1.47

0.74

1.0

—

Necrosis of pulp, including avohilmo

1.60

0.74

1.0

—

Excessive, frequent and irregular menstruation

1.64

0.73

1.0

—

Other reaction to severe stress, and adjustment disorders

1.64

0.73

1.0

—

Anomalies of dental arch relationship, including avohilmo

1.80

0.72

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

2.00

0.72

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

1.62

0.72

1.0

—

Metabolic disorders

1.48

0.72

1.0

—

Coxibs

2.03

0.72

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.62

0.72

1.0

—

First line medication for Crohn's disease

1.40

0.72

1.0

—

Pain in throat and chest

1.48

0.71

1.0

—

Anaemias

1.76

0.71

1.0

—

Other congenital malformations

1.92

0.70

1.0

—

Other systemic involvement of connective tissue (FG)

1.90

0.70

1.0

—

Paralytic ileus and intestinal obstruction

1.85

0.68

1.0

—

Injuries to the thorax

1.67

0.68

1.0

—

Irregular menses

1.53

0.67

1.0

—

Disorders of refraction and accommodation

1.62

0.66

1.0

—

Other disorders of ear

1.45

0.66

1.0

—

Other systemic involvement of connective tissue

1.79

0.66

1.0

—

Constipation

1.46

0.65

1.0

—

Oedema, not elsewhere classified

1.76

0.65

1.0

—

Noninflammatory disorders of female genital tract

1.67

0.65

1.0

—

Postpartum care and examination

1.76

0.64

1.0

—

Insomnia

1.41

0.63

1.0

—

Other obstetric conditions, not elsewhere classified

1.59

0.63

1.0

—

Diseases of male genital organs

1.61

0.62

1.0

—

Degenerative diseases of the nervous system

0.00

0.61

0.0

1.0

—

Other degenerative diseases of the nervous system

0.00

0.61

0.0

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.60

0.61

1.0

—

L04AA Selective immunosuppressants

1.67

0.61

1.0

—

Endometriosis ASRM stages 3,4

1.67

0.61

1.0

—

Functional dyspepsia

1.67

0.61

1.0

—

Other specified/unspecified arthritis

1.67

0.61

1.0

—

Nutritional anaemias

1.61

0.61

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.61

0.0

1.0

—

Diseases of inner ear

1.58

0.60

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.60

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.60

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

0.60

0.0

1.0

—

Concussion

1.55

0.60

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.60

0.0

1.0

—

Lichen planus, including avohilmo

0.00

0.60

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.60

0.0

1.0

—

Single spontaneous delivery

1.57

0.59

1.0

—

Diabetes mellitus in pregnancy

1.60

0.59

1.0

—

Schizophrenia

0.00

0.59

0.0

1.0

—

Sequelae with surgical and medical care as external cause

0.00

0.59

0.0

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.52

0.58

1.0

—

Dermatophytosis

1.53

0.58

1.0

—

Other noninfective gastroenteritis and colitis

1.71

0.57

1.0

—

Atrial fibrillation and flutter

1.69

0.57

1.0

—

Excessive attrition of teeth

1.48

0.57

1.0

—

DVT of lower extremities and pulmonary embolism

1.66

0.56

1.0

—

Other disorders of veins

1.66

0.56

1.0

—

Gingivitis and periodontal diseases

1.39

0.56

1.0

—

Other and unspecified anaemias

1.63

0.56

1.0

—

Other anaemias

1.63

0.55

1.0

—

Tooth eruption problems

1.58

0.54

1.0

—

In situ neoplasms

1.58

0.54

1.0

—

Type 1 diabetes

1.58

0.54

1.0

—

Complications of medical and surgical care

1.44

0.54

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

0.67

0.54

1.0

—

Pure hypercholesterolaemia

1.47

0.54

1.0

—

Disorders of breast

1.49

0.53

1.0

—

Disorders of choroid and retina

1.50

0.53

1.0

—

Superficial injury of lower leg

1.54

0.53

1.0

—

Hernia of abdominal wall

1.54

0.53

1.0

—

Ischaemic heart disease, wide definition

1.55

0.53

1.0

—

ILD medications: immunosuppressive drugs

1.45

0.51

1.0

—

Artrosis, including avohilmo

0.64

0.51

1.0

—

Inflammatory bowel disease treatment related agents

1.31

0.51

1.0

—

Other intervertebral disc disorders

1.40

0.49

1.0

—

Pregnancy with abortive outcome

0.65

0.48

1.0

—

Arthropathies

1.32

0.47

1.0

—

Neoplasms

1.32

0.47

1.0

—

Iron deficiency anaemia

1.47

0.47

1.0

—

Angina pectoris

1.46

0.47

1.0

—

Tramadol

1.39

0.46

1.0

—

Ovarian cyst

1.44

0.46

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.32

0.46

1.0

—

Disorders of the thyroid gland

1.33

0.46

1.0

—

All pneumoniae

103

1.30

0.46

1.0

—

Type 2 diabetes

1.31

0.44

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.29

0.43

1.0

—

Other neurological diseases

1.45

0.43

1.0

—

Polycystic ovarian syndrome, consortium definition

1.33

0.43

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.30

0.43

1.0

—

Injuries to the knee and lower leg

101

1.26

0.43

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.61

0.43

1.0

—

Glucosamine medication

1.60

0.43

1.0

—

Insulin, intermediate and long-acting

1.44

0.42

1.0

—

Renal failure

1.58

0.42

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.43

0.42

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.56

0.42

1.0

—

Influenza and pneumonia

105

1.27

0.42

1.0

—

Outcome of delivery

1.55

0.42

1.0

—

Alzheimer disease

0.00

0.42

0.0

1.0

—

Atopic dermatitis, strict definition

1.40

0.42

1.0

—

Use of anticholinesterases

0.00

0.41

0.0

1.0

—

N06DA Anticholinesterases

0.00

0.41

0.0

1.0

—

COPD (mode)

0.00

0.41

0.0

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.41

0.0

1.0

—

Symptoms and signs involving the urinary system

1.38

0.41

1.0

—

Polyp of the female genital tract

1.51

0.41

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.41

0.0

1.0

—

Hypo-osmolality and hyponatraemia

0.00

0.41

0.0

1.0

—

Recurrent dislocation and subluxation of joint

0.00

0.41

0.0

1.0

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.41

0.0

1.0

—

Deep endometriosis

0.00

0.41

0.0

1.0

—

Twin gestation

0.00

0.41

0.0

1.0

—

Disorders of optic nerve and visual pathways

0.00

0.41

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

0.41

0.0

1.0

—

Multiple gestation

0.00

0.41

0.0

1.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.41

0.0

1.0

—

Benign neoplasm: Rectum

0.00

0.41

0.0

1.0

—

Acute and transient psychotic disorders

0.00

0.41

0.0

1.0

—

Lichen planus

0.00

0.41

0.0

1.0

—

Abnormal involuntary movements

0.00

0.41

0.0

1.0

—

Methotrexate

0.00

0.41

0.0

1.0

—

Gout, FINNGEN

0.00

0.41

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.41

0.0

1.0

—

Operations 2 for CAVS

0.00

0.41

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.41

0.0

1.0

—

Alzheimer disease, including avohilmo

0.00

0.41

0.0

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.44

0.41

1.0

—

Thyroiditis, ILD-related definition

0.00

0.40

0.0

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

0.40

0.0

1.0

—

Aneurysms, operations, SAH

0.00

0.40

0.0

1.0

—

Other skin changes

0.00

0.40

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.40

0.0

1.0

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.40

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

0.40

0.0

1.0

—

Gastroduodenal ulcer

0.00

0.40

0.0

1.0

—

Cardiac murmurs and other cardiac sounds

0.00

0.40

0.0

1.0

—

Used for control exclusion in common control thyroid runs

1.28

0.40

1.0

—

Gonarthrosis,primary

1.41

0.40

1.0

—

Calcific aortic valvular stenosis, operated

0.00

0.40

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

0.40

0.0

1.0

—

Specific personality disorders

1.47

0.40

1.0

—

Agranulocytosis

0.00

0.40

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.40

0.0

1.0

—

Foreign body on external eye

0.00

0.40

0.0

1.0

—

Other symptoms and signs involving the digestive system and abdomen

0.00

0.40

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.40

0.0

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.39

0.0

1.0

—

Autoimmune diseases excluding thyroid diseases

1.28

0.39

1.0

—

Benign paroxysmal vertigo

1.43

0.39

1.0

—

Migraine with aura

1.43

0.39

1.0

—

Diabetes mellitus

1.28

0.39

1.0

—

Dorsopathies

1.27

0.39

1.0

—

Family history of malignant neoplasm

0.00

0.39

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

0.39

0.0

1.0

—

Renal tubulo-interstitial diseases

1.31

0.39

1.0

—

Other dorsopathies, not elsewhere classified

1.27

0.38

1.0

—

Unspecified haematuria

1.38

0.38

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.33

0.37

1.0

—

Arthrosis

0.64

0.37

1.0

—

Lumbar disc prolapse

1.30

0.37

1.0

—

Herpesviral [herpes simplex] infections

1.35

0.37

1.0

—

Personality disorders, excluding more controls

1.35

0.37

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.28

0.36

1.0

—

Acute tubulo-interstitial nephritis

1.27

0.36

1.0

—

Haemorrhage in early pregnancy

1.46

0.36

1.0

—

Complications of labour and delivery

1.32

0.36

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.30

0.36

1.0

—

Hypothyroidism and >3 levothyroxin purchases

1.41

0.36

1.0

—

Hypothyroidism, levothyroxine purchases

1.41

0.36

1.0

—

Other heart diseases, wide

1.26

0.35

1.0

—

Aplastic and other anaemias

1.43

0.35

1.0

—

Insulin, fast-acting

1.43

0.35

1.0

—

Spondylopathies

1.37

0.35

1.0

—

Viral and other specified intestinal infections

1.39

0.35

1.0

—

Rheumatoid arthritis, including avohilmo

1.40

0.35

1.0

—

Insulin, fast-acting or short human

1.39

0.35

1.0

—

Hypothyroidism (congenital or acquired)

1.36

0.34

1.0

—

Disorders of skin appendages

1.37

0.34

1.0

—

Single delivery by caesarean section

1.32

0.33

1.0

—

Appendectomy

1.32

0.33

1.0

—

Endocrine, nutritional and metabolic diseases

1.27

0.33

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

103

1.24

0.33

1.0

—

Other arthrosis

1.30

0.33

1.0

—

Emergency coronary revascularization (for ACS)

0.72

0.32

1.0

—

Other and unspecified tonsillitis

1.31

0.30

1.0

—

Other diseases of urinary system

1.23

0.30

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

107

0.79

0.30

1.0

—

Intracranial trauma

1.31

0.28

1.0

—

Antihypertensive medication - note that there are other indications

1.23

0.28

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.29

0.28

1.0

—

Visual disturbances

1.27

0.27

1.0

—

Sensorineural hearing loss

1.23

0.27

1.0

—

Visual disturbances and blindness

1.23

0.27

1.0

—

Tonsillectomy and adenotomy

1.25

0.27

1.0

—

Diabetes medication

1.21

0.27

1.0

—

Noninfective enteritis and colitis

1.19

0.26

1.0

—

Insulin medication

1.26

0.26

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.21

0.25

1.0

—

Other heart diseases

0.73

0.24

1.0

—

Menorrhagia

1.39

0.24

1.0

—

L04AX Other immunosuppressants

1.17

0.24

1.0

—

Supervision of high-risk pregnancy

1.37

0.24

1.0

—

Benign neoplasms

0.81

0.24

1.0

—

Second line medication for Crohn's disease

1.28

0.24

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.22

0.23

1.0

—

Transient ischemic attack

1.31

0.23

1.0

—

Any reimbursement code in KELA

1.23

0.23

1.0

—

Other benign neoplasms of skin

1.28

0.23

1.0

—

Psychiatric diseases

1.20

0.22

1.0

—

Implicit Sepsis

0.74

0.22

1.0

—

Statin medication

1.25

0.22

1.0

—

All-cause Heart Failure

1.22

0.22

1.0

—

Coronary artery bypass grafting

0.00

0.22

0.0

1.0

—

Status post-ami

0.00

0.21

0.0

1.0

—

Sub-endpoint used in defining T1D endpoints

1.20

0.21

1.0

—

AV-block

0.00

0.21

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

0.21

0.0

1.0

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

0.21

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.21

0.0

1.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

0.00

0.21

0.0

1.0

—

Personality disorders

1.19

0.21

1.0

—

Diabetic nephropathy

0.00

0.21

0.0

1.0

—

Bacterial Sepsis

1.19

0.21

1.0

—

Infections of breast associated with childbirth

0.00

0.21

0.0

1.0

—

Dissociative [conversion] disorders

0.00

0.21

0.0

1.0

—

Placenta praevia

0.00

0.21

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.21

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

0.21

0.0

1.0

—

Failed induction of labour

0.00

0.21

0.0

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.21

0.0

1.0

—

Viral hepatitis

0.00

0.21

0.0

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Heterophoria

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.0

—

Ulcerative rectosigmoiditis

0.00

0.21

0.0

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to tobacco

0.00

0.21

0.0

1.0

—

Other diseases of biliary tract

0.00

0.21

0.0

1.0

—

Smoking dependency

0.00

0.21

0.0

1.0

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.21

0.0

1.0

—

Other peripheral vertigo

0.00

0.21

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.21

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.21

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

0.21

0.0

1.0

—

Benign neoplasm of meninges

0.00

0.21

0.0

1.0

—

Diseases of peritoneum

0.00

0.21

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.21

0.0

1.0

—

Heartburn

0.00

0.21

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

1.0

—

Hypotension

0.00

0.21

0.0

1.0

—

Peripheral arterial reconstruction

0.00

0.21

0.0

1.0

—

Malignant melanoma

0.00

0.21

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

0.21

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

0.21

0.0

1.0

—

Gastric ulcer

0.00

0.21

0.0

1.0

—

Gout, unspecified

0.00

0.21

0.0

1.0

—

Use of donepezil

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.0

—

Hyperplasia of prostate

0.00

0.21

0.0

1.0

—

Heart failure,strict

1.18

0.21

1.0

—

Heart failure, strict

1.18

0.21

1.0

—

Other (not insulin) diabetes medications

1.20

0.21

1.0

—

Gout

0.00

0.21

0.0

1.0

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.21

0.0

1.0

—

Demyelinating diseases of the central nervous system

0.00

0.21

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

0.21

0.0

1.0

—

Hallux rigidus

0.00

0.21

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.21

0.0

1.0

—

Cholecystitis

0.00

0.21

0.0

1.0

—

Disorders of speech understanding and production

0.00

0.21

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

0.21

0.0

1.0

—

Diabetic nephropathy, excluding more controls

0.00

0.21

0.0

1.0

—

Fracture at wrist and hand level

1.16

0.21

1.0

—

Ankylosing spondylitis, ICD10

0.00

0.21

0.0

1.0

—

Ankylosing spondylitis

0.00

0.21

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Glomerulonephritis

0.00

0.21

0.0

1.0

—

Primary hyperparathyroidism

0.00

0.21

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

0.21

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.21

0.0

1.0

—

Hypokalaemia

0.00

0.21

0.0

1.0

—

Radiculopathy

0.00

0.21

0.0

1.0

—

Gout, idiopatic and unspecified

0.00

0.21

0.0

1.0

—

Secondary hypertension

0.00

0.20

0.0

1.0

—

Disorders of vestibular function (Vertigo)

1.26

0.20

1.0

—

Polycystic ovarian syndrome

0.00

0.20

0.0

1.0

—

Impacted maxillary molar

0.00

0.20

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.20

0.0

1.0

—

Sarcoidosis

0.00

0.20

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.20

0.0

1.0

—

Chronic apical periodontitis

0.84

0.20

1.0

—

Injuries to the head

106

1.16

0.20

1.0

—

Maternal care for other known or suspected fetal problems

1.15

0.19

1.0

—

Delivery, wide proxy

1.24

0.19

1.0

—

False labour

1.18

0.18

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.16

0.17

1.0

—

Procreative management

1.14

0.17

1.0

—

Disorders of lens

0.73

0.17

1.0

—

Cerebrovascular diseases

0.75

0.17

1.0

—

Pneumonia, organism unspecified

1.17

0.17

1.0

—

Contact with and exposure to communicable diseases

0.73

0.17

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.19

0.16

1.0

—

Osteopathies and chondropathies

1.18

0.16

1.0

—

Fall on same level involving ice and snow

1.16

0.16

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.14

0.16

1.0

—

Reimbursement for rheumatic diseases

1.12

0.16

1.0

—

Hypertensive diseases (excluding secondary)

0.74

0.16

1.0

—

Erysipelas

0.75

0.15

1.0

—

Malignant neoplasm

0.83

0.15

1.0

—

Persons with potential health hazards related to communicable diseases

0.77

0.15

1.0

—

Any event in cancer register

0.86

0.15

1.0

—

Percutaneous Coronary Intervention

0.78

0.15

1.0

—

Coronary revascularization (ANGIO or CABG)

0.78

0.15

1.0

—

All kidney diseases

102

1.14

0.14

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

1.18

0.14

1.0

—

Hypertension

0.85

0.13

1.0

—

Hypertensive diseases

0.85

0.13

1.0

—

Spontaneous abortion

1.18

0.12

1.0

—

Other bacterial diseases

0.88

0.12

1.0

—

Diabetes, varying definitions

1.12

0.11

1.0

—

Explicit Sepsis

1.14

0.10

1.0

—

Disorders of adult personality and behaviour

1.11

0.09

1.0

—

Inflammatory bowel disease

1.11

0.09

1.0

—

Syncope and collapse

1.07

0.09

1.0

—

Labour and delivery complicated by fetal stress [distress]

1.06

0.09

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

105

1.10

0.09

1.0

—

Fracture of shoulder and upper arm

1.06

0.09

1.0

—

Open wound of wrist and hand

1.04

0.09

1.0

—

Persons encountering health services in circumstances related to reproduction

1.14

0.09

1.0

—

Other diseases of lip and oral mucosa

1.11

0.09

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.07

0.08

1.0

—

STROKE

1.05

0.08

1.0

—

Other functional intestinal disorders

1.05

0.08

1.0

—

Periapical abscess

1.05

0.08

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

0.89

0.08

1.0

—

Substance abuse

0.77

0.08

1.0

—

1.08

0.08

1.0

—

Other abnormal products of conception

1.05

0.08

1.0

—

Fracture of lower leg, including ankle

1.07

0.08

1.0

—

Hypertension, essential

1.13

0.08

1.0

—

Artificial joint operation, meniscal resection

1.14

0.07

1.0

—

Conductive and sensorineural hearing loss

1.08

0.07

1.0

—

Type 2 diabetes, wide definition

1.07

0.07

1.0

—

Infections with a predominantly sexual mode of transmission

0.80

0.07

1.0

—

Intracranial injury

1.04

0.07

1.0

—

Cholecystectomy

0.86

0.07

1.0

—

Periodontitis

0.90

0.07

1.0

—

Acute appendicitis, no complications

0.83

0.07

1.0

—

Leiomyoma of uterus

0.84

0.07

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.89

0.07

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.89

0.07

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.88

0.07

1.0

—

Polyarthropathies

1.13

0.06

1.0

—

Implicit Sepsis

0.88

0.06

1.0

—

Other disorders of urethra and urinary system

0.85

0.06

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.10

0.06

1.0

—

Certain infectious and parasitic diseases

1.10

0.06

1.0

—

Chronic periodontitis, including avohilmo

0.91

0.05

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.09

0.05

1.0

—

Type 2 diabetes, definitions combined

1.09

0.05

1.0

—

Autoimmune diseases related-to ILD

102

0.92

0.04

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.93

0.03

1.0

—

Viral infections characterized by skin and mucous membrane lesions

110

0.93

0.03

1.0

—

Solid cancers, helper endpoint

0.92

0.03

1.0

—

Biguanides

1.08

0.03

1.0

—

Mycoses

107

1.06

0.01

1.0

—

Cystitis

1.05

0.01

1.0

—

Injuries to the elbow and forearm

0.94

0.00

1.0

—

Hard cardiovascular diseases

0.96

0.00

1.0

—

Appendicitis, broad definition

0.97

0.00

1.0

—

Cholelithiasis, broad definition with cholecystitis

0.96

0.00

1.0

—

Diseases of appendix

0.97

0.00

1.0

—

Other bacterial diseases

0.97

0.00

1.0

—

Disorders of gallbladder, biliary tract and pancreas

0.96

0.00

1.0

—

Cardiovascular diseases

0.97

0.00

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.98

0.00

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.02

0.00

1.0

—

Cholelithiasis

1.03

0.00

1.0

—

Malignant neoplasm, wide definition for exclusion

1.04

0.00

1.0

—

Cholangitis (primary sclerosing, PSC)

0.00

0.0

1.0

—

Speech disturbances, not elsewhere classified

0.00

0.0

1.0

—

Optic neuritis

0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

0.0

1.0

—

Retinal vascular disorders

0.00

0.0

1.0

—

Gout, strict definition

0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

0.0

1.0

—

Chronic periodontitis, complicated

1.01

0.00

1.0

—

Other and unspecified iridocyclitis

0.00

0.0

1.0

—

Other diseases of arteries and capillaries

0.00

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.0

—

Hyperkinetic disorders (excl. ADHD)

0.00

0.0

1.0

—

Allergic colitis

0.00

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

0.0

1.0

—

Implicit fungal Sepsis

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

0.0

1.0

—

Other viral hepatitis

0.00

0.0

1.0

—

Respiratory distress of newborn

0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.0

1.0

—

Retinal vascular occlusion

0.00

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

0.0

1.0

—

Hypertrophic scar

0.00

0.0

1.0

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.0

—

Ulcerative enterocolitis

0.00

0.0

1.0

—

Amputation

0.00

0.0

1.0

—

Malignant neoplasm of breast

0.96

0.00

1.0

—

Mild mental retardation

0.00

0.0

1.0

—

Vestibular neuronitis

0.00

0.0

1.0

—

Rare circulating lymphoid malignancy, including Hilmo

0.00

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.0

—

Injury of other and unspecified intrathoracic organs

0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

1.0

—

Other and unspecified mental retardation

0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

0.0

1.0

—

Substance abuse, excluding more controls

0.85

0.00

1.0

—

Congenital malformations of the respiratory system

0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

0.0

1.0

—

Use of antiglaucoma preparations and miotics

0.00

-0.00

0.0

1.0

—

Exclusion endpoint for clefts

0.00

-0.00

0.0

1.0

—

Placental disorders

0.00

-0.00

0.0

1.0

—

Pregnancy, childbirth and the puerperium

1.00

-0.00

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

-0.00

0.0

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.89

-0.00

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Other inflammation of vagina/vulva

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

-0.00

0.0

1.0

—

Other obstructed labour

0.00

-0.00

0.0

1.0

—

Abscess of Bartholin gland

0.00

-0.00

0.0

1.0

—

Congenital deformities of hip

0.00

-0.00

0.0

1.0

—

Torsion of testis

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the vagina

0.00

-0.00

0.0

1.0

—

Other osteochondropathies

0.00

-0.00

0.0

1.0

—

Osteomyelitis

0.00

-0.00

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

Other and unspecified myopathies

0.00

-0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

-0.00

0.0

1.0

—

Lung cancer and mesothelioma

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Exclusion endpoint for supernumerary teeth

0.00

-0.00

0.0

1.0

—

Other inflammatory liver diseases

0.00

-0.00

0.0

1.0

—

Senile cataract

0.85

-0.00

1.0

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

-0.00

0.0

1.0

—

Lung diseases due to external agents

0.00

-0.00

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

1.0

—

Invasive ventilation

0.00

-0.00

0.0

1.0

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Viral hepatitis, IBD co-morbidity

0.00

-0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

-0.00

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.0

—

Ischemic heart diseases

0.96

-0.00

1.0

—

Oesophageal varices

0.00

-0.00

0.0

1.0

—

Intracerebral haemorrhage

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.0

—

Convergent concomitant strabismus

0.00

-0.00

0.0

1.0

—

Heart failure, not strict

0.99

-0.00

1.0

—

Inguinal or femoral hernia, bilateral

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to psychoactive substance use

0.91

-0.00

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

Conduct disorder

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.0

—

Visual impairment including blindness (binocular or monocular)

0.00

-0.00

0.0

1.0

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

Other sleep disorders

0.00

-0.00

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.0

—

Anankastic personality disorder

0.00

-0.00

0.0

1.0

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.0

—

Acute appendicitis

0.93

-0.00

1.0

—

Disorder of the sleep-wake schedule

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

1.0

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Other disorders of nervous system

0.00

-0.00

0.0

1.0

—

Isolated growth hormone deficiency

0.00

-0.00

0.0

1.0

—

Thrombocytopenia, unspecified

0.00

-0.00

0.0

1.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Other disorders of cornea

0.00

-0.00

0.0

1.0

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Infections with a predominantly sexual mode of transmission

0.92

-0.00

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Venous complications and haemorrhoids in pregnancy

0.00

-0.00

0.0

1.0

—

Dilated cardiomyopathy

0.00

-0.00

0.0

1.0

—

Papillary adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

-0.00

0.0

1.0

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung

0.00

-0.00

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.92

-0.00

1.0

—

Contraceptive management

1.00

-0.00

1.0

—

Conotruncal defects

0.00

-0.00

0.0

1.0

—

Scabies

0.00

-0.00

0.0

1.0

—

Gingival hyperplasia

0.00

-0.00

0.0

1.0

—

Disorders of mineral metabolism

0.00

-0.00

0.0

1.0

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.0

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Atrial septal defect, secundum type

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

-0.00

0.0

1.0

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

-0.00

0.0

1.0

—

Other assisted single delivery

0.00

-0.00

0.0

1.0

—

Atrial septal defect

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Congenital malformations of the nervous system

0.00

-0.00

0.0

1.0

—

Synovial cyst of popliteal space [Baker]

0.00

-0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

-0.00

0.0

1.0

—

Alcohol use disorder, Swedish definition

0.90

-0.00

1.0

—

Pyogenic arthritis

0.00

-0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Inguinal hernia, bilateral

0.00

-0.00

0.0

1.0

—

Erysipelas

0.92

-0.00

1.0

—

Caries in Clefts patients

0.00

-0.00

0.0

1.0

—

Cleft lip, lip and palate or palate

0.00

-0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Ptosis of eyelid

0.00

-0.00

0.0

1.0

—

Fracture of forearm

0.88

-0.00

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Parotid gland

0.00

-0.00

0.0

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

1.0

—

Other necrotizing vasculopathies

0.00

-0.00

0.0

1.0

—

Other/unspecified reactive arthropathies

0.00

-0.00

0.0

1.0

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.0

—

Event of undetermined intent

0.00

-0.00

0.0

1.0

—

!Aliquae complicationes praecoces traumatis

0.00

-0.00

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

-0.00

0.0

1.0

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.0

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

1.0

—

Undescended testicle

0.00

-0.00

0.0

1.0

—

Behavioural disorders

0.00

-0.00

0.0

1.0

—

Disorders of other endocrine glands

0.89

-0.00

1.0

—

Other disorders originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.0

—

Myocarditis

0.00

-0.00

0.0

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.94

-0.00

1.0

—

Acute peritonitis

0.00

-0.00

0.0

1.0

—

Disorders of calcium metabolism

0.00

-0.00

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

-0.00

0.0

1.0

—

Other and unspecified vascular occlusions

0.00

-0.00

0.0

1.0

—

0.97

-0.00

1.0

—

Care involving dialysis

0.00

-0.00

0.0

1.0

—

Other CVD (FINNGEN)

0.00

-0.00

0.0

1.0

—

Persistent delusional disorders

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of psychological development

0.00

-0.00

0.0

1.0

—

Male infertility

0.00

-0.00

0.0

1.0

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

-0.00

0.0

1.0

—

Special screening examination for other diseases and disorders

0.00

-0.00

0.0

1.0

—

Behavioural disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Tic and related disorders

0.00

-0.00

0.0

1.0

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

1.0

—

Extracorporeal dialysis

0.00

-0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Fall on and from ladder

0.00

-0.00

0.0

1.0

—

Contact with heat and hot substances

0.00

-0.00

0.0

1.0

—

Injury of unspecified body region

0.00

-0.00

0.0

1.0

—

Thiazolidinediones

0.00

-0.00

0.0

1.0

—

Tongue abnormality

0.00

-0.00

0.0

1.0

—

Early complications of trauma

0.00

-0.00

0.0

1.0

—

Foreign body in alimentary tract

0.00

-0.00

0.0

1.0

—

Diverticular disease of intestine

0.89

-0.00

1.0

—

Focal brain injury

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of head

0.00

-0.00

0.0

1.0

—

Faecal incontinence

0.00

-0.00

0.0

1.0

—

All chronic kidney diseases

0.93

-0.00

1.0

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

0.00

-0.00

0.0

1.0

—

Pregnancy hypertension

0.96

-0.00

1.0

—

Fentanyl

0.00

-0.00

0.0

1.0

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

Abnormal weight loss

0.00

-0.00

0.0

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

1.0

—

Juvenile rheumatoid arthirtis

0.00

-0.00

0.0

1.0

—

Congenital deformities of hip

0.00

-0.00

0.0

1.0

—

Major coronary heart disease event

0.95

-0.00

1.0

—

Malignant neoplasm of breast, including Hilmo

0.92

-0.00

1.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Smooth Alder IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS